Recombinant Human TFE3 Protein，His

TFE3 (Transcription Factor E3) is a member of the microphthalmia-associated transcription factor (MITF) family, which plays a crucial role in various biological processes, including cell differentiation, proliferation, and responses to environmental stimuli. Recently, TFE3 has garnered attention due to its involvement in specific types of cancers and its function as a crucial regulator in the autophagy pathway. Research has demonstrated that TFE3 is activated in response to stress conditions, leading to the transcription of genes that facilitate cellular survival and adaptation. Notably, TFE3 can undergo translocation in certain tumors, resulting in aberrant activation and contributing to oncogenesis. This has spurred interest in its potential as a therapeutic target and biomarker for cancer diagnosis and prognosis. Moreover, TFE3 has been implicated in various cellular processes, such as lysosomal biogenesis and metabolism, influencing both normal physiology and disease states. The production of recombinant TFE3 protein allows for detailed studies of its structure-function relationships, cellular roles, and the mechanisms underlying its regulation. Understanding TFE3's functions and interactions at the molecular level could unveil novel therapeutic strategies for conditions where TFE3 is dysregulated, thereby highlighting its significance in both basic research and clinical applications.